evenfolio

FMCG · NSE: CUPID

Cupid

Q2 FY27 earnings highlights, from the results presentation

Price as of 16 Nov 2026
361.90−4.21%

Q2 FY27 · From the investor presentation

Read the filing on NSEFiling

₹880​CrRevenue · FY27Slides · p. 17
4,000​storesModern trade stores listed · Domestic FMCG · FY27Slides · p. 29
₹275​CrNet profit · FY27Slides · p. 17
₹1,305​CrRevenue · FY28Slides · p. 52
M.Cap
₹48,663Cr
P/E
287.2×
1Y return
+478.39%
From 52W high
−7.9%

Highlights are read by AI from the company's filing and can contain mistakes. Check the source page linked to each line.

Share price

Guidance

Revenue · FY27Rs 880 CrFY27 revenue guidance raised to at least Rs 880 crore
Revenue · FY28Rs 1,305 CrFY28 revenue guided at Rs 1,305 crore or more
Revenue · FY29Rs 1,950 CrFY29 revenue guided at Rs 1,950 crore or more
Revenue · H2 FY27Rs 514 CrH2 FY27 implied at Rs 514 crore+ total income
Net profit · FY27Rs 275 CrFY27 net profit guidance raised to Rs 275 crore or more
Net profit · FY28Rs 390 CrFY28 net profit guided at about Rs 390 crore
Net profit · FY29Rs 605 CrFY29 net profit guided at about Rs 605 crore
Net profit · H2 FY27Rs 175 CrImplied H2 PAT of Rs 175 crore+, called the strongest half-year

H2 FY27 expected stronger than H1 as Palava is commissioned in Q3

Slides · Chairman & Managing Director · p. 17
“We expect H2 FY27 to be stronger than H1, as Palava is to be commissioned in Q3 and both partnerships scale up.”

More figures from the presentation

Company · Capacity
770​million pieces p.a.Male condom capacity added
“+770 Million male / +75 Million female condoms p.a.”
Slidesp. 32
Company · Capacity
1.25​billion pieces p.a.Male condom capacity
“480 Million → ~1.25 Billion”
Slidesp. 32
Company · Capacity
125​million pieces p.a.Female condom capacity
“52 Million → ~125 Million”
Slidesp. 32

In short

  1. 01FY27 guidance raised to at least Rs 880 crore revenue and Rs 275 crore+ net profit.
  2. 02Medium-term guidance: FY28 revenue Rs 1,305 crore+ and FY29 Rs 1,950 crore+, with net profit about Rs 390 crore and Rs 605 crore.
  3. 03H1 FY27 operating income grew 137% to Rs 342.58 crore; Q2 revenue rose 122% year on year.
  4. 04H2 FY27 expected stronger than H1, with Palava to be commissioned in Q3 FY27.
  5. 05Style Baazar expected to add about Rs 200 crore in FY27; V2 Retail seen as a Rs 400 crore opportunity over 12 months.
  6. 06Palava adds 770 million male and 75 million female condoms a year, taking male capacity to about 1.25 billion.
  7. 07Management says it will make the company debt-free over time.

Capex

Palava plant of about 170,000 sq ft, latex and nitrile, targeted for Q3 FY27

Slides · p. 32
“~170,000 sq. ft.; latex + nitrile; Q3 FY27”

Capacity

IVD: IVD kit capacity to go from about 4 lakh to about 8 lakh kits a day

Slides · p. 32
“Kits/day: ~4 Lakhs → ~8 Lakhs”

Order book

Exports: Long-term PFSCM supply agreement from Q1 FY27

Slides · p. 34
“Long-term PFSCM supply agreement from Q1 FY27 (Mar 2026)”

Exports: South Africa programme 2025-30 worth about US$12.98 million a year

Slides · p. 34
“South Africa programme 2025–30: ~US$12.98 Million p.a.”

Exports: South Africa programme: 23.4 million female condoms a year

Slides · p. 21
“– 23.4 Million female condoms p.a.”

Segments

Domestic FMCG: Style Baazar expected to contribute about Rs 200 crore in FY27

Slides · Chairman & Managing Director · p. 17
“Style Baazar is expected to contribute about ₹200 crore in FY27”

Domestic FMCG: V2 Retail seen as about Rs 400 crore opportunity over next 12 months

Slides · Chairman & Managing Director · p. 17
“V2 Retail offers an estimated ₹400 crore opportunity over the next 12 months.”

Domestic FMCG: Style Baazar network to exceed 500 stores in 2-3 years

Slides · p. 25
“● Style Baazar network to exceed 500 stores in 2–3 years”

IVD: IVD: State Government orders expected

Slides · p. 23
“State Government orders expected”

Exports: H1 FY27 exports Rs 112.73 crore (33.4%); domestic Rs 224.64 crore (66.6%)

Slides · p. 10
“₹112.73 Crores 33.4% ₹224.64 Crores 66.6%”

Margins and costs

Q2 FY27 EBITDA Rs 54.77 crore, down 8.8% from Rs 60.06 crore in Q1

Slides · p. 16
“EBITDA 54.77 60.06 (8.8)% 28.41 92.8% 114.83 44.89 155.8%”

Exports: Minimum 10% price increase implemented

Slides · p. 13
“Minimum 10% price increase implemented”

H1 FY27 EBITDA margin 33.5%

Slides · p. 12
“H1 FY27 33.5%”

Q2 FY27 raw material cost Rs 97.38 crore, up 184.4% year on year

Slides · p. 16
“Raw material & changes in inventories 97.38 64.79 50.3% 34.24 184.4% 162.17 58.33 178.0%”

Debt and working capital

Management says it will make the company debt-free over time

Slides · Chairman & Managing Director · p. 17
“will make the Company debt-free as we go along.”

FY26 current borrowings Rs 38.81 crore, up from Rs 12.63 crore

Slides · p. 44
“Current borrowings 12.06 12.63 38.81”

FY26 cash and bank balances Rs 186.45 crore

Slides · p. 44
“Cash & bank balances 39.45 68.57 186.45”

FY26 non-current borrowings Rs 12.17 crore, nil in FY24 and FY25

Slides · p. 44
“Non-current borrowings – – 12.17”

Acquisitions and new business

South Africa: South Africa manufacturing venture is asset-light, Cupid stake up to 49%

Slides · p. 32
“Asset-light; Cupid stake up to 49%”

South Africa: Partner to fund capex and working capital of South Africa venture

Slides · p. 32
“Partner funds capex & working capital”

West Bengal: West Bengal project: land and feasibility under evaluation

Slides · p. 32
“Land & feasibility under evaluation”

56 lakh Baazar Style warrants still pending

Slides · p. 34
“56 Lakhs pending; ₹193.67 Crores”

Follow-on investment made in July 2026

Slides · p. 34
“Follow-on investment (Jul 2026)”

Other

H1 FY27 operating income grew 137% to Rs 342.58 crore

Slides · Chairman & Managing Director · p. 17
“H1 FY27 reflects strong business momentum: operating income grew 137% to ₹342.58”

H1 FY27 net profit rose 156% to Rs 100.37 crore

Slides · Chairman & Managing Director · p. 17
“net profit rose 156% to ₹100.37 crore.”

Q2 FY27 revenue up 122%, EBITDA up 93%, PAT up 133% year on year

Slides · p. 14
“Q2 FY27 vs Q2 FY26: revenue +122%, EBITDA +93%, PAT +133%.”

Domestic Consumer Healthcare & FMCG: Domestic consumer healthcare and FMCG was 49% of H1 revenue

Slides · Chairman & Managing Director · p. 17
“Domestic Consumer Healthcare & FMCG contributed 49% of H1 revenue”

Revenue guidance up 47% from the original

Slides · p. 18
“▲ Revenue guidance up 47% from the original”

Sources

Management's own statements, quoted from its NSE filings. This page was read by AI and can contain mistakes: check the source pages before relying on any figure. No forecast or opinion of ours. Not investment advice.

Search

Search funds, ETFs, stocks, pages and tools